The New Drug That Might Cure HIV!

New strides are being made everyday in the prevention and cure of HIV.

Kaiser Permanente in San Francisco performed a study tracking 600 gay men for two years while they used a drug called Truvada, otherwise known as PrEP or “pre-exposure prophylaxis.” The drug was taken to prevent the contraction of HIV and it worked with none of the participants testing HIV-positive.

Truvada was used in a real-world setting as opposed to a clinical one. The participants used Truvada for seven months, with some reported having several partners in a short span of time and this was referred to by researchers as a high-risk setting, but still no new HIV cases were found.

The drug has faced its share of criticism with being called a “party drug” and concerns that those who use Truvada won’t use condoms. Truvada only prevents HIV and not other sexually transmitted diseases.

Even though there were no cases of HIV in this study, 30 percent of participants contracted an STI within a year, 50 percent contracted an STI within two years, 56 percent of participants said their use of condoms remained unchanged and 41 percent said they used condoms less.

Truvada does seem to be doing something significant in the prevention of HIV, but it should also be stressed by providers for the drug’s users to still practice safe sex.

Brittney Fennell

Brittney Fennell

Brittney is the Associate Editor of Jawbreaker and a writer who has goals to disrupt culture in ways unseen.